AMA advises physicians to order influenza vaccine

In order to ensure the availability of influenza vaccine for administration early this coming fall, the AMA recommends that physicians and providers begin to order supplies of influenza vaccine immediately. In 2003, large numbers of cases of influenza began to appear in October, and activity was widespread. Anticipation of increased demand for vaccine in the Fall of 2004 makes it imperative that physicians and providers who care for Medicare beneficiaries and others at high risk for complications from influenza begin to prepare for the 2004-05 influenza season immediately.

According to the Centers for Medicare and Medicaid Services (CMS), while the recently enacted Medicare Prescription Drug, Improvement and Modernization Act of 2003 changed the Medicare payments for many covered drugs and biologicals, the basis for Medicare payment of influenza vaccine will continue to be 95 percent of the average wholesale price.

Each year, the AMA convenes public health experts from around the country in its National Influenza Summit. The Summit includes discussion on vaccine production, recommendations for vaccination and general influenza prevention. The conference takes place April 13-14 – stay tuned to the AMA Web site for coverage of this event.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CHOP study shows safety of rotavirus vaccine in neonatal intensive care unit